Table 2 Summary of study results for the study group and with distinction of subgroups based on the SCORE2 scale.

Blood pressure [mmHg]

SBP M ± SD

127 ± 17.3

122 ± 12.4

135 ± 17.2

144.5 ± 17.4

 < 0.001^a

SBP ≥ 140

249 (29.8)

29 (7.6)

111 (39.4)

109 (63.1)

 < 0.001^b

DBP M ± SD

80 ± 10.1

78 ± 8.1

84 ± 10.2

88 ± 11.7

 < 0.001^b

DBP ≥ 80

176 (21.1)

29 (7.6)

82 (29.1)

65 (37.6)

 < 0.001^a

Heart action [beats per minute]

M ± SD

73 ± 10.7

73 ± 9.8

74 ± 11

76 ± 11.7

0.005^b

 ≤ 50

54 (6.5)

25 (6.6)

15 (5.3)

14 (8.1)

0.698^a

 ≥ 90

19 (2.2)

5 (1.3)

8 (2.9)

6 (3.5)

Total cholesterol [mg/dl]

M ± SD

204 ± 4.2

198 ± 31.6

209 ± 42.1

222.7 ± 44.9

 < 0.001^b

 ≥ 190

523 (62,6)

234 (61.4)

182 (64.5)

107 (61.8)

 < 0.000^a

LDL [mg/dl]

M ± SD

122 ± 136.8

118 ± 21.6

130 ± 37.8

138 ± 41.1

 < 0.001^b

 ≥ 100 for patients with low to medium risk of CV events

552 (66.1)

248 (65.1)

185 (65.6)

119 (68.8)

0.684^a

 ≥ 70 for patients with high risk of CV events

 ≥ 55 for patients with very high ris k of CV events

HDL [mg/dl]

M ± SD

58 ± 15.6

62 ± 14.4

57 ± 16.5

58 ± 15.5

 < 0.001^b

 ≤ 40 for female

101 (12.1)

46 (12.1)

35 (12.4)

20 (11.6)

0.964^a

 ≤ 45 for males

Non-HDL [mg/dl]

M ± SD

142 ± 40.5

136 ± 31.9

153 ± 41.8

165 ± 42.5

 < 0.001^b

 ≥ 130 for patients with low to medium risk of CV events

419 (50.1)

182 (47.8)

145 (51.4)

92 (53.2)

0.431^a

 ≥ 100 for patients with high risk of CV events

 ≥ 85 for patients with very high risk of CV events

Triglycerides [mg/dl]

M ± SD

98 ± 64.4

101 ± 52.8

125 ± 60.7

140 ± 77.1

 < 0.001^b

 ≥ 150

160 (19.2)

64 (16.8)

63 (22.3)

33 (19.1)

0.200^a

Glucose [mg/dl]

M ± SD

92 ± 16.8

90 ± 8.5

95 ± 12.4

102 ± 33.1

 < 0.001^b

 ≥ 100

184 (22.1)

82 (22.5)

64 (22.7)

38 (21.9)

0.937^a